Abstract A068: Post-transcriptional regulation driven by NAT10 in ovarian cancer

Abstract Introduction- Protein synthesis in cancer is frequently dysregulated, highlighting translational regulatory mechanisms as promising treatment targets. The epitranscriptome, which includes more than 140 chemical modifications of RNA, plays a significant role in regulating protein synthesis. For example, N-acetyltransferase 10 (NAT10), which acetylates cytidines (N4-acetylcytidine or ac4C) in RNA, is notably overexpressed in various cancers. However, the specific impact of RNA ac4C modification in high-grade serous ovarian cancer (HGSOC) remains incompletely understood. This project aims to characterize the underlying oncogenic mechanisms of the NAT10/ac4C axis. Methods: We performed acetylated RNA immunoprecipitation sequencing (acRIP-seq) to identify the mRNA targets of NAT10. To investigate the impact of NAT10-overexpressing macrophages on tumor progression, we utilized a Csf1r -/- ovarian cancer in vivo model. Furthermore, we employed flow cytometry to evaluate how NAT10 expression influences immune cell infiltration within the tumor microenvironment. Results: We observed that macrophages exposed to conditioned medium from ovarian cancer cells exhibit increased NAT10 expression, accompanied by elevated levels of RNA acetylation. Moreover, enhanced NAT10 expression in macrophages promotes an immunosuppressive phenotype, characterized by upregulation of CD206, IL-10, IL-1β, and Arginase. Flow cytometry analysis revealed that NAT10 overexpression in macrophages impairs T-cell infiltration and contributes to an immunosuppressive tumor microenvironment by reducing the population of activated T cells. Furthermore, inhibition of NAT10 in the tumor microenvironment reduces ovarian cancer growth in a mouse model. acRIP sequencing identified 978 differentially acetylated peaks, including 211 that were hyperacetylated. The associated genes were enriched in pathways related to mRNA processing, ribosome biogenesis, RNA splicing, and regulation of translation initiation. Conclusions: Our study provides a novel mechanism by which macrophages within a tumor microenvironment acquire their immunosuppressive phenotype and identifies an important link among mRNA acetylation, macrophage immunosuppression, and tumor progression. This study suggests a new strategy for restoring the anti-tumor phenotype of macrophages by reducing NAT10 expression. Citation Format: Sonam Mittal, Shirng-Wern Tsaih, Ishaque Pulikkal Kadamberi, Sudhir Kumar, Mona Singh, Chandrima Dey, Jasmine George, Rahimi Arezou, Anjali Geethadevi, Anupama A Nair, Pradeep Chaluvally-Raghavan, Sunila Pradeep. Post-transcriptional regulation driven by NAT10 in ovarian cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research; 2025 Sep 19-21; Denver, CO. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl):Abstract nr A068.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-09-19
DOI
https://doi.org/10.1158/1538-7445.ovarian25-a068
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A068: Post-transcriptional regulation driven by NAT10 in ovarian cancer

Anjali Geethadevi, Sudhir Kumar, Chandrima Dey, Shirng‐Wern Tsaih et al.
Cancer Research
RNA modifications and cancer
article

Abstract A068: Post-transcriptional regulation driven by NAT10 in ovarian cancer

Anjali Geethadevi, Sudhir Kumar, Chandrima Dey, Shirng‐Wern Tsaih, Sunila Pradeep, Ishaque P. Kadamberi, Pradeep Chaluvally–Raghavan, Jasmine George, A. Nair, Mona Singh, Sonam Mittal, Rahimi Arezou
article en

Abstract

Abstract Introduction- Protein synthesis in cancer is frequently dysregulated, highlighting translational regulatory mechanisms as promising treatment targets. The epitranscriptome, which includes more than 140 chemical modifications of RNA, plays a significant role in regulating protein synthesis. For example, N-acetyltransferase 10 (NAT10), which acetylates cytidines (N4-acetylcytidine or ac4C) in RNA, is notably overexpressed in various cancers. However, the specific impact of RNA ac4C modification in high-grade serous ovarian cancer (HGSOC) remains incompletely understood. This project aims to characterize the underlying oncogenic mechanisms of the NAT10/ac4C axis. Methods: We performed acetylated RNA immunoprecipitation sequencing (acRIP-seq) to identify the mRNA targets of NAT10. To investigate the impact of NAT10-overexpressing macrophages on tumor progression, we utilized a Csf1r -/- ovarian cancer in vivo model. Furthermore, we employed flow cytometry to evaluate how NAT10 expression influences immune cell infiltration within the tumor microenvironment. Results: We observed that macrophages exposed to conditioned medium from ovarian cancer cells exhibit increased NAT10 expression, accompanied by elevated levels of RNA acetylation. Moreover, enhanced NAT10 expression in macrophages promotes an immunosuppressive phenotype, characterized by upregulation of CD206, IL-10, IL-1β, and Arginase. Flow cytometry analysis revealed that NAT10 overexpression in macrophages impairs T-cell infiltration and contributes to an immunosuppressive tumor microenvironment by reducing the population of activated T cells. Furthermore, inhibition of NAT10 in the tumor microenvironment reduces ovarian cancer growth in a mouse model. acRIP sequencing identified 978 differentially acetylated peaks, including 211 that were hyperacetylated. The associated genes were enriched in pathways related to mRNA processing, ribosome biogenesis, RNA splicing, and regulation of translation initiation. Conclusions: Our study provides a novel mechanism by which macrophages within a tumor microenvironment acquire their immunosuppressive phenotype and identifies an important link among mRNA acetylation, macrophage immunosuppression, and tumor progression. This study suggests a new strategy for restoring the anti-tumor phenotype of macrophages by reducing NAT10 expression. Citation Format: Sonam Mittal, Shirng-Wern Tsaih, Ishaque Pulikkal Kadamberi, Sudhir Kumar, Mona Singh, Chandrima Dey, Jasmine George, Rahimi Arezou, Anjali Geethadevi, Anupama A Nair, Pradeep Chaluvally-Raghavan, Sunila Pradeep. Post-transcriptional regulation driven by NAT10 in ovarian cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research; 2025 Sep 19-21; Denver, CO. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl):Abstract nr A068.

Cancer ResearchVol. 85(18_Supplement)
Emory University (US), Medical College of Wisconsin (US)
Openalex Percentile: Top 78%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.